Schülke & Mayr

📍 Hamburg, Germany🗓 Founded 1889👥 461 employees💰 Last funded Sep 2022
Pharmaceutical Manufacturing🌐 schuelke.com
Website LinkedIn
For 135 years, we stand for pioneering spirit, innovation and quality. Founded by Rudolf Schülke and Julius Mayr in 1889, we have established ourself today as an internationally operating and successful chemical and pharmaceutical company. We develop, produce and distribute over 300 products worldwide, including disinfectants, antiseptics, medical and cosmetic skin care products, preservatives and deodorant active ingredients. With strong brands such as octenisept®, microshield®, desmanol®, mikrozid® and sensiva® SC 50, we are one of the international market leaders in the areas of hygiene, infection prevention and treatment. We offer our customers innovative technologies, products and services in our four strategic business fields Healthcare, Industrial Hygiene, Over the Counter (OTC) and Direct Patient Care. We are headquartered in Germany and have over 1200 passionate & motivated employees worldwide. We sell our products in over 100 countries. Represented by 20 subsidiaries and a network of sales partners we operate three production sites in Germany (schülke), France (Bioxal) and Brazil (Vic Pharma). Imprint: https://www.schuelke.com/intl-en/imprint/
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1889
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Frequently asked questions
Who invested in Schülke & Mayr?
Schülke & Mayr has 1 investors on record on gritt.io.
When did Schülke & Mayr last raise funding?
The most recent investment in Schülke & Mayr recorded on gritt.io was in September 2022.
When was Schülke & Mayr founded?
Schülke & Mayr was founded in 1889.
What industry is Schülke & Mayr in?
Schülke & Mayr operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Schülke & Mayr based?
Schülke & Mayr is headquartered in Hamburg, Germany.